1. From the Studies Coordinating Centre, Hypertension and Cardiovascular Rehabilitation Unit, Department of Cardiovascular Diseases, University of Leuven, Belgium (J.G.W., J.A.S., R.F., T.N.); the Centre for Epidemiological Studies and Clinical Trials, Ruijin Hospital, Shanghai Institute of Hypertension, Shanghai Jiaotong University, China (J.G.W., Y.L.); the Heymans Institute of Pharmacology, University of Ghent, Belgium (L.V.B.); the Hypertension Program, Division of Cardiology, St. Luke’s-Roosevelt...